35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020)

The Society for Immunotherapy of Cancer’s (SITC) 35^th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) will be reimagined as a fully VIRTUAL experience this year to ensure the health and safety of program attendees and their patients, and in celebration of the society’s 35^th anniversary, all SITC members are invited to register for FREE!

Registration and other details will be announced soon!

Important Dates

• April 1 – Regular abstracts, Young Investigator Award abstracts, late-breaking abstract applications and Immunotherapy Resistance and Failure Pre-Conference Program presentation application submission open
• Aug. 25 – Regular abstracts, Young Investigator Award abstracts, late-breaking abstract applications and Immunotherapy Resistance and Failure Pre-Conference Program presentation application submission close
• Sept. 4 – Branding and advertising commitment deadline 
• Sept. 8 – Late-Breaking Abstract submission period open 
• Sept. 22 – Late-Breaking Abstract submission period close
• Oct. 26 – Pre-registration mailing lists available
• Nov. 30 – Post-Annual Meeting mailing lists available

Thank You to Our Organizers

Annual Program Committee CHAIR

Sandra Demaria, MD – Weill Cornell Medicine

35^th Anniversary Annual Meeting Organizers

Helen E. Heslop, MD – Baylor College of Medicine
Brianna W. Hoffner, MSN, ANP-BC, AOCNP – Harborside
Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai
Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
Jedd D. Wolchok, MD, PhD – Memorial Sloan Kettering Cancer Center

35^th Anniversary Annual Meeting Program Committee Members

Ana Carrizosa Anderson, PhD – Harvard Medical School
Davide Bedognetti, MD, PhD – Sidra Medicine
Marianne Davies, DNP, AOCNP – Yale School of Nursing
Patrick Hwu, MD – Moffitt Cancer Center

Immunotherapy Resistance and Failure

Kald Abdallah, MD, PhD – Bristol-Myers Squibb
Edward Cha, MD, PhD – Genentech
Jennifer Gansert, MD, PhD – Amgen 
Israel Lowy, MD, PhD – Regeneron Pharmaceuticals
Giovanni Melillo, MD – AstraZeneca
Eric Rubin, MD – Merck & Co., Inc.

Primer on tumor immunology and cancer Immunotherapy™ Organizers

Michael A. Curran, PhD – The University of Texas MD Anderson Cancer Center
Yvonne Saenger, MD – Columbia University Irving Medical Center

workshop on engineering immune cells for cancer therapy

Christine Brown, PhD – City of Hope
Katayoun Rezvani, MD, PhD – The University of Texas MD Anderson Cancer Center
Marco Ruella, MD – University of Pennsylvania

Grant writing workshop

David Aggen, MD, PhD – Memorial Sloan Kettering Cancer Center
Olivia Rongze Lu, PhD – University of Texas at Austin
Claire Vanpouille-Box, PhD – Weill Cornell Medical College
Grey Wilkinson, PhD – Oncolytics Biotech Inc.

Keynotes Announced

Keynote address: Turning immunologically quiescent tumors into immune responsive cancers

Elizabeth M. Jaffee, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

35^th Anniversary Keynote: t cell therapy of cancer

Helen E. Heslop, MD – Baylor College of Medicine

richard v. smalley, md, memorial award and lectureship

Lieping Chen, MD, PhD – Yale Cancer Center
Gordon Freeman, PhD – Dana-Farber Cancer Institute
Arlene Sharpe, MD, PhD – Harvard Medical School

View the SITC Meeting Code of Conduct.